Labelling of CRF1 and CRF2 receptors using the novel radioligand, [3H]-urocortin.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Neuropharmacology

• Publication date

  1997-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0028-3908(97)00098-1PMID 9423932
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.

  1996cited by this paper
• Corticotrophin-releasing factor receptors: from molecular biology to drug design.

  1996cited by this paper
• CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.

  1996cited by this paper
• Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid.

  1996cited by this paper
• Cloning and characterization of human urocortin.

  1996cited by this paper
• Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides.

  1995cited by this paper
• Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor

  1995cited by this paper
• Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain.

  1995cited by this paper
• A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle.

  1995cited by this paper
• Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart.

  1995cited by this paper
• Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression

  1995cited by this paper
• Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart.

  1995cited by this paper
• Chapter 3. Heterogeneity of Corticotropin Releasing Factor Receptors: Multiple Targets for the Treatment of CNS and Inflammatory Disorders

  1995cited by this paper
• The role of corticotropin-releasing factor in the pathophysiology of affective and anxiety disorders: laboratory and clinical studies.

  1993cited by this paper
• Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors

  1993cited by this paper
• Expression cloning of a human corticotropin-releasing-factor receptor.

  1993cited by this paper
• Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain.

  1993cited by this paper
• Corticotropin-Releasing Factor

  1989cited by this paper
• Corticotropin-releasing factor receptors in the rat central nervous system: characterization and regional distribution

  1987cited by this paper
• Ligand: a versatile computerized approach for characterization of ligand-binding systems.

  1980cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper

• Network analysis of transcriptomics data for the prediction and prioritization of membrane-associated biomarkers for idiopathic pulmonary fibrosis (IPF) by bioinformatics approach.

  2021cites this paper
• Kinetic Profile of Neuropeptide-Receptor Interactions.

  2016cites this paper
• Corticotropin-releasing factor receptor type-2 is involved in the cocaine-primed reinstatement of cocaine conditioned place preference in rats.

  2014cites this paper
• Molecular Mechanisms Involved in the Regulation of Circadian Clock Gene and Neuropeptide Transcription: Influence of Palmitate

  2012cites this paper
• Roles of two subtypes of corticotrophin‐releasing factor receptor in the corticostriatal long‐term potentiation under cocaine withdrawal condition

  2010cites this paper
• Stimulation of the inferior olivary complex alters the distribution of the type 1 corticotropin releasing factor receptor in the adult rat cerebellar cortex.

  2008cites this paper
• Involvement of corticotropin-releasing factor receptor 2 beta in differentiation of dopaminergic MN9D cells.

  2008cites this paper
• Emerging Anxiolytics: Corticotropin‐Releasing Factor Receptor Antagonists

  2007cites this paper
• Differences in response to corticotropin-releasing factor after short- and long-term consumption of a high-fat diet.

  2007cites this paper
• Corticotropin releasing hormone--a GPCR drug target.

  2007cites this paper
• CORTICOTROPHIN RELEASING HORMONE MODULATION OF FEED INTAKE, GASTRIC MOTILITY, AND BEHAVIOR IN LOW AND HIGH BODY WEIGHT SELECTED LINES OF CHICKENS

  2005cites this paper
• Regulation of gene expression and survival in cellular stress

  2005cites this paper
• Corticotropin-releasing hormone and urocortin induce secretion of matrix metalloproteinase-9 (MMP-9) without change in tissue inhibitors of MMP-1 by cultured cells from human placenta and fetal membranes.

  2005cites this paper
• Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart.

  2004cites this paper
• Binding differences of human and amphibian corticotropin-releasing factor type 1 (CRF(1)) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonism.

  2004cites this paper
• Corticotropin-releasing factor receptor 1-deficient mice do not develop postoperative gastric ileus.

  2003cites this paper
• Conformational states of the corticotropin releasing factor 1 (CRF1) receptor: detection, and pharmacological evaluation by peptide ligands.

  2003cites this paper
• Localization of the type 1 corticotropin releasing factor receptor (CRF-R1) in the embryonic mouse cerebellum

  2003cites this paper
• The pharmacology of CP-154,526, a non-peptide antagonist of the CRH1 receptor: a review.

  2003cites this paper
• Intraperitoneal corticotropin-releasing factor and urocortin induce Fos expression in brain and spinal autonomic nuclei and long lasting stimulation of colonic motility in rats.

  2003cites this paper
• Urocortin: a mechanism for the sustained activation of the HPA axis in the late-gestation ovine fetus?

  2002cites this paper
• Activation of protein kinase B/Akt by urocortin is essential for its ability to protect cardiac cells against hypoxia/reoxygenation-induced cell death.

  2002cites this paper
• Antalarmin, a putative CRH-RI antagonist, has transient reinforcing effects in rhesus monkeys

  2002cites this paper
• Characterization of urocortin in human pregnancy.

  2001cites this paper
• Molecular biology of the CRH receptors-- in the mood.

  2001cites this paper
• Inhibition of mouse melanoma cell proliferation by corticotropin-releasing hormone and its analogs.

  2001cites this paper
• 125I-Antisauvagine-30: a novel and specific high-affinity radioligand for the characterization of corticotropin-releasing factor type 2 receptors.

  2001cites this paper
• Role of brain arachidonic acid cascade on central CRF1 receptor-mediated activation of sympatho-adrenomedullary outflow in rats.

  2001cites this paper
• Urocortin protects against ischemic injury via a MAPK-dependent pathway.

  2001cites this paper
• Neurochemical studies with St. John's wort in vitro.

  2001cites this paper
• Peripheral corticotropin-releasing factor and stress-stimulated colonic motor activity involve type 1 receptor in rats.

  2000cites this paper
• Urocortin Protects against Ischemic and Reperfusion Injury via a MAPK-dependent Pathway*

  2000cites this paper
• Cellular localization of corticotropin releasing factor receptors in the adult mouse cerebellum.

  2000cites this paper
• Localization and characterization of urocortin during human pregnancy.

  2000cites this paper
• The neurobiology of urocortin.

  2000cites this paper
• Comparison of central administration of corticotropin-releasing hormone and urocortin on food intake, conditioned taste aversion, and c-Fos expression.

  2000cites this paper
• The role of CRF receptor subtypes in stress-induced behavioural responses.

  2000cites this paper
• Bisanthraquinone glycosides of Hypericum perforatum with binding inhibition to CRH-1 receptors.

  2000cites this paper
• Neuropeptides as emerging targets in anorexia and cachexia

  2000cites this paper
• Urocortin stimulates placental adrenocorticotropin and prostaglandin release and myometrial contractility in vitro.

  1999cites this paper
• Human CRF2 α and β splice variants: pharmacological characterization using radioligand binding and a luciferase gene expression assay

  1999cites this paper
• Human CRF2 alpha and beta splice variants: pharmacological characterization using radioligand binding and a luciferase gene expression assay.

  1999cites this paper
• The ligand‐selective Domains of Corticotropin‐Releasing Factor Type 1 and Type 2 Receptor Reside in Different Extracellular Domains

  1999cites this paper
• Functional, endogenously expressed corticotropin‐releasing factor receptor type 1 (CRF1) and CRF1 receptor mRNA expression in human neuroblastoma SH‐SY5Y cells

  1999cites this paper
• CRH-like peptides protect cardiac myocytes from lethal ischaemic injury.

  1999cites this paper
• Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors.

  1999cites this paper
• Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30.

  1998cites this paper
• Pharmacological characterisation of the recombinant human CRF binding protein using a simple assay.

  1998cites this paper